For: | Yarema R, Оhorchak М, Hyrya P, Kovalchuk Y, Safiyan V, Karelin I, Ferneza S, Fetsych M, Matusyak M, Oliynyk Y, Fetsych Т. Gastric cancer with peritoneal metastases: Efficiency of standard treatment methods. World J Gastrointest Oncol 2020; 12(5): 569-581 [PMID: 32461788 DOI: 10.4251/wjgo.v12.i5.569] |
---|---|
URL: | https://www.wjgnet.com/1948-5204/full/v12/i5/569.htm |
Number | Citing Articles |
1 |
Martynas Luksta, Augustinas Bausys, Klaudija Bickaite, Rokas Rackauskas, Marius Paskonis, Raminta Luksaite-Lukste, Anastasija Ranceva, Rokas Stulpinas, Birute Brasiuniene, Edita Baltruskeviciene, Nadezda Lachej, Rasa Sabaliauskaite, Rimantas Bausys, Skaiste Tulyte, Kestutis Strupas. Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with cisplatin and doxorubicin in combination with FOLFOX chemotherapy as a first-line treatment for gastric cancer patients with peritoneal metastases: single-arm phase II study. BMC Cancer 2023; 23(1) doi: 10.1186/s12885-023-11549-z
|
2 |
Zhifang Zhang, Annie Yang, Shyambabu Chaurasiya, Anthony K. Park, Sang-In Kim, Jianming Lu, Hannah Valencia, Yuman Fong, Yanghee Woo. Anti-Tumor Immunogenicity of the Oncolytic Virus CF33-hNIS-antiPDL1 against Ex Vivo Peritoneal Cells from Gastric Cancer Patients. International Journal of Molecular Sciences 2023; 24(18): 14189 doi: 10.3390/ijms241814189
|
3 |
Kazuya Takahashi, Kentaro Kurashina, Hironori Yamaguchi, Rihito Kanamaru, Hideyuki Ohzawa, Hideyo Miyato, Shin Saito, Yoshinori Hosoya, Alan Kawarai Lefor, Naohiro Sata, Joji Kitayama. Altered intraperitoneal immune microenvironment in patients with peritoneal metastases from gastric cancer. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.969468
|
4 |
Niccolò Allievi, Federica Bianco, Michele Pisano, Giulia Montori, Paola Fugazzola, Federico Coccolini, Marco Lotti, Stefania Mosconi, Barbara Merelli, Luca Campanati, Alessandro Lucianetti, Luca Ansaloni, Stefano Magnone. Hyperthermic intraperitoneal chemotherapy (HIPEC) as adjuvant and therapeutic options for patients with advanced gastric cancer at high risk of recurrence or established peritoneal metastases: a single-centre experience. Updates in Surgery 2023; 75(1): 159 doi: 10.1007/s13304-022-01399-y
|
5 |
Zhouwei Zhan, Xiaojie Wang, Jiami Yu, Jingxian Zheng, Yi Zeng, Mingyao Sun, Li Peng, Zengqing Guo, Bijuan Chen. Intraperitoneal Infusion of Recombinant Human Endostatin Improves Prognosis in Gastric Cancer Ascites. Future Oncology 2022; 18(10): 1259 doi: 10.2217/fon-2021-0896
|
6 |
|
7 |
Rémy Sindayigaya, Can Dogan, Cédric Remy Demtröder, Britta Fischer, Elias Karam, Jonathan Robin Buggisch, Clemens B. Tempfer, Thierry Lecomte, Mehdi Ouaissi, Urs Giger-Pabst. Clinical Outcome for Patients Managed with Low-Dose Cisplatin and Doxorubicin Delivered as Pressurized Intraperitoneal Aerosol Chemotherapy for Unresectable Peritoneal Metastases of Gastric Cancer. Annals of Surgical Oncology 2022; 29(1): 112 doi: 10.1245/s10434-021-10860-y
|
8 |
Xiangdong Cheng, Enyu Dai, Jibo Wu, Natasha M. Flores, Yanshuo Chu, Ruiping Wang, Minghao Dang, Zhiyuan Xu, Guangchun Han, Yunhe Liu, Deyali Chatterjee, Can Hu, Jieer Ying, Yian Du, Litao Yang, Xiaoqing Guan, Shaowei Mo, Xuanye Cao, Guangsheng Pei, Jiahui Jiang, Xiaoyin Lu, Ana Morales Benitez, Rebecca E. Waters, Melissa Pool Pizzi, Namita Shanbhag, Yibo Fan, Fuduan Peng, Samir M. Hanash, George Calin, Andrew Futreal, Shumei Song, Cassian Yee, Pawel K. Mazur, Jiang-Jiang Qin, Jaffer A. Ajani, Linghua Wang. Atlas of Metastatic Gastric Cancer Links Ferroptosis to Disease Progression and Immunotherapy Response. Gastroenterology 2024; doi: 10.1053/j.gastro.2024.07.038
|
9 |
Soo Jin Park, Eun Ji Lee, Hee Su Lee, Junsik Kim, Sunwoo Park, Jiyeon Ham, Jaehee Mun, Haerin Paik, Hyunji Lim, Aeran Seol, Ga Won Yim, Seung-Hyuk Shim, Beong-Cheol Kang, Suk Joon Chang, Whasun Lim, Gwonhwa Song, Jae-Weon Kim, Nara Lee, Ji Won Park, Jung Chan Lee, Hee Seung Kim. Development of rotational intraperitoneal pressurized aerosol chemotherapy to enhance drug delivery into the peritoneum. Drug Delivery 2021; 28(1): 1179 doi: 10.1080/10717544.2021.1937382
|
10 |
Si Ying Adelina Ho, Kon Voi Tay. Systematic review of diagnostic tools for peritoneal metastasis in gastric cancer-staging laparoscopy and its alternatives. World Journal of Gastrointestinal Surgery 2023; 15(10): 2280-2293 doi: 10.4240/wjgs.v15.i10.2280
Abstract(299) |
Core Tip(254) |
Full Article(HTML)(1480)
|
Full Article with Cover (PDF)-1061K(66)
|
Full Article (Word)-608K(24)
|
Audio-669K(4)
|
Peer-Review Report-272K(30)
|
Answering Reviewers-55K(32)
|
Supplementary Material-71K(32)
|
Full Article (PDF)-854K(92)
|
Full Article (XML)-169K(36)
|
Times Cited (2)
|
Total Visits (3818)
|
Open
|
11 |
Yongchao Yang, Junliang Zhang. Ascites-derived hsa-miR-181a-5p serves as a prognostic marker for gastric cancer-associated malignant ascites. BMC Genomics 2024; 25(1) doi: 10.1186/s12864-024-10359-2
|
12 |
Can Yurttas, Philipp Horvath, Imma Fischer, Silvia Wagner, Karolin Thiel, Ruth Ladurner, Ingmar Königsrainer, Alfred Königsrainer, Matthias Schwab, Stefan Beckert, Markus W. Löffler. Fluorescence-Guided Laparoscopy after Oral Hypericin Administration for Staging of Locally Advanced Gastric Cancer—A Pilot Study. Journal of Clinical Medicine 2024; 13(8): 2422 doi: 10.3390/jcm13082422
|
13 |
Emerson Lucena da Silva, Felipe Pantoja Mesquita, Adrhyann Jullyanne de Sousa Portilho, Emanuel Cintra Austregésilo Bezerra, Julio Paulino Daniel, Elenn Suzany Pereira Aranha, Sarah Farran, Marne Carvalho de Vasconcellos, Maria Elisabete Amaral de Moraes, Caroline Aquino Moreira-Nunes, Raquel Carvalho Montenegro. Differences in glucose concentration shows new perspectives in gastric cancer metabolism. Toxicology in Vitro 2022; 82: 105357 doi: 10.1016/j.tiv.2022.105357
|
14 |
Deanna Ng, Aiman Ali, Kiera Lee, Denise Eymael, Kento Abe, Shelly Luu, Karineh Kazazian, Yi Qing Lu, Savtaj Brar, James Conner, Marco Magalhaes, Carol J. Swallow. Investigating the mechanisms of peritoneal metastasis in gastric adenocarcinoma using a novel ex vivo peritoneal explant model. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-13948-x
|
15 |
Diana Galos, Loredana Balacescu, Radu Vidra, Daniel Sur. Real-World Data on Second-Line Therapy with Ramucirumab for Metastatic Gastric Cancer: A Two-Center Study on Romanian Population. Life 2023; 13(12): 2300 doi: 10.3390/life13122300
|
16 |
Kohei Tamura, Natsuka Kimura, Hideyuki Ohzawa, Hideyo Miyato, Naohiro Sata, Takahiro Koyanagi, Yasushi Saga, Yuji Takei, Hiroyuki Fujiwara, Ryozo Nagai, Joji Kitayama, Kenichi Aizawa. Optimizing Timing of Intraperitoneal Chemotherapy to Enhance Intravenous Carboplatin Concentration. Cancers 2024; 16(16): 2841 doi: 10.3390/cancers16162841
|
17 |
Shuang Dai, Yan Huang, Ting Liu, Zi-Han Xu, Tao Liu, Lan Chen, Zhi-Wu Wang, Feng Luo. Development and validation of RNA binding protein-applied prediction model for gastric cancer. Aging 2021; 13(4): 5539 doi: 10.18632/aging.202483
|
18 |
Wonyoung Choi, Yun-Hee Kim, Sang Myung Woo, Yebeen Yu, Mi Rim Lee, Woo Jin Lee, Jung Won Chun, Sung Hoon Sim, Heejung Chae, Hyoeun Shim, Keun Seok Lee, Sun-Young Kong. Establishment of Patient-Derived Organoids Using Ascitic or Pleural Fluid from Cancer Patients. Cancer Research and Treatment 2023; 55(4): 1077 doi: 10.4143/crt.2022.1630
|
19 |
Daryl K. A. Chia, Raghav Sundar, Guowei Kim, Jia Jun Ang, Jeffrey H. Y. Lum, Min En Nga, Giap Hean Goh, Ju Ee Seet, Cheng Ean Chee, Hon Lyn Tan, Jingshan Ho, Natalie Y. L. Ngoi, Matilda X. W. Lee, Vaishnavi Muthu, Gloria H. J. Chan, Angela S. L. Pang, Yvonne L. E. Ang, Joan R. E. Choo, Joline S. J. Lim, Jun Liang Teh, Aung Lwin, Yuen Soon, Asim Shabbir, Jimmy B. Y. So, Wei Peng Yong. Outcomes of a Phase II Study of Intraperitoneal Paclitaxel plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases. Annals of Surgical Oncology 2022; 29(13): 8597 doi: 10.1245/s10434-022-11998-z
|
20 |
Jiazheng Li, Lin Cong, Xuefeng Sun, Xiaoting Li, Yang Chen, Jieyuan Cai, Meng He, Xiaotian Zhang, Lei Tang. CT characteristics for predicting prognosis of gastric cancer with synchronous peritoneal metastasis. Frontiers in Oncology 2023; 12 doi: 10.3389/fonc.2022.1061806
|